NMRA
Neumora Therapeutics Inc.
$2.09
+$0.02(+0.97%)
30
Overall
60
Value
10
Tech
21
Quality
Market Cap
$432.76M
Volume
618.11K
52W Range
$0.61 - $11.57
Target Price
$9.17
EPS Estimates Overview
| Current Quarter | $-0.34 | Next Quarter | $-0.32 |
| Current Year | $-1.44 | Next Year | $-0.99 |
| QoQ Growth | +5.9% | YoY Growth | +31.3% |
| 3Y EPS CAGR | N/A | Target Price | $9.17 |
| Consensus | Buy | Upside | +338.8% |
Quarterly EPS Estimates
Revenue Analysis
| Current Quarter Rev | N/A | Next Quarter Rev | N/A |
| Revenue Growth | N/A | YoY Growth | N/A |
Estimates are based on analyst consensus and subject to revision. Past performance does not guarantee future results.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | NMRA | $2.09 | +1.0% | 618.11K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Neumora Therapeutics Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW